FDA.reportPublic FDA data

eltrombopag 54 MG Oral Tablet [Alvaiz]

RxCUI
2675201
RxNorm name
eltrombopag 54 MG Oral Tablet [Alvaiz]
Display name
eltrombopag 54 MG Oral Tablet [Alvaiz]
Full name
eltrombopag 54 MG Oral Tablet [Alvaiz]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ALVAIZELTROMBOPAGTeva Pharmaceuticals, Inc.ed51e463-7a03-4858-bbd2-882ce4753d5a2026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2675201

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ed51e463-7a03-4858-bbd2-882ce4753d5aAlvaiz 54 MG Oral Tablet [PSN] · eltrombopag 54 MG Oral Tablet [Alvaiz] [SBD] · Alvaiz 54 MG (eltrombopag choline 66.6 MG) Oral Tablet [SY] · Alvaiz 54 MG Oral Tablet [SY]47These highlights do not include all the information needed to use ALVAIZ safely and effectively. See full prescribing information for ALVAIZ . ALVAIZ ® (eltrombopag tablets), for oral use Initial U.S. Approval: 200820260130